Blood tests were performed to 98.5 % of the pregnant women in the intervention group, detecting an anemia prevalence (Hb <11 g/dL) of 37 % (280 women), and identifying 42 cases (5.5 %) with hemoglobin levels under 9 g/dL. This evidence concerns the gene GSTM1 and anemia.